| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/30/2002 | US6380221 Ortho-anthranilamide derivatives as anti-coagulants |
| 04/30/2002 | US6380220 Therapy of neurodegenerative diseases and neuronal injuries which are casued by ischemia, trauma or massive hemorrhages |
| 04/30/2002 | US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal |
| 04/30/2002 | US6380215 For prevention and/or treatment of diseases caused by thrombus formation such as arterial thrombosis, arterial sclerosis, ischemic heart diseases |
| 04/30/2002 | US6380213 Compounds useful as neuro-protective agents |
| 04/30/2002 | US6380204 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist activity |
| 04/30/2002 | US6380201 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists |
| 04/30/2002 | US6380191 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/30/2002 | US6380189 2-amino benzoxazinones for the treatment of viral infections |
| 04/30/2002 | US6380186 Psychotherapeutic agents |
| 04/30/2002 | US6379823 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032897A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 04/25/2002 | WO2002032896A1 Furazanyl-triazole derivates for the treatment of diseases |
| 04/25/2002 | WO2002032894A1 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 04/25/2002 | WO2002032893A2 Piperidine compounds as anti-allergic |
| 04/25/2002 | WO2002032886A1 A process for the preparation of bis-benzazolyl compounds |
| 04/25/2002 | WO2002032884A2 Methods for the preparation of biphenyl isoxazole sulfonamides |
| 04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
| 04/25/2002 | WO2002032857A1 Methods of producing oxazolidinone compounds |
| 04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | WO2002010137A3 Indazole derivatives as JNK inhibitors |
| 04/25/2002 | WO2001081341A3 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations |
| 04/25/2002 | WO2001002369A3 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 04/25/2002 | US20020049337 4-(2-amino-1-hydroxyethyl)oxazoline derivative and method for producing same |
| 04/25/2002 | US20020049330 Such as 5-(N,N-dibenzyl)aminocarbonyl-2-pyridone; enzyme inhibitors; for treatment of Alzheimer's disease |
| 04/25/2002 | US20020049329 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 04/25/2002 | US20020049243 Pyrrolidine derivatives |
| 04/25/2002 | US20020049241 Conformationally rigid bicyclic and adamantane derivatives useful as alpha2-adrenergic blocking agents |
| 04/25/2002 | US20020049236 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/25/2002 | US20020049223 Quinoline and naphthyridine carboxylic acid antibacterials |
| 04/25/2002 | US20020049222 Cyclopentyl modulators of chemokine receptor activity |
| 04/25/2002 | US20020049220 Substituted azoles |
| 04/25/2002 | US20020049217 Peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras |
| 04/25/2002 | US20020049213 Converting a benzaldehyde compound to an oxime in presence of hydroxylamine/hydrochloric acid and pyridine in methylene chloride, converting to intermediateand racting it with methoxyphenyl acetylene to form intermediate then final comp |
| 04/25/2002 | US20020049211 Combination treatment for depression and anxiety |
| 04/25/2002 | US20020049204 1,4-dihydro-benzo(d)oxazin-2-one derivatives useful for treating hormone-dependent neoplastic disease is selected from uterine myometrial fibroids, endometriosis, benign prostatic hypertrophy, carcinomas, and adenocarcinoma |
| 04/25/2002 | US20020049202 Administering halogenated amidino or oxyamidino compound to treat diseases caused by nitric oxide synthase |
| 04/25/2002 | US20020049201 Sulfonamide inhibitors of aspartyl protease |
| 04/25/2002 | US20020049197 Aminoquinazolines and their use as medicaments |
| 04/25/2002 | US20020049195 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc. |
| 04/25/2002 | US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist |
| 04/25/2002 | US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity. |
| 04/25/2002 | US20020049187 2-(azetidin-2-on-1-yl) acetic acid derivatives; treatment of obsessive-compulsive disorder |
| 04/25/2002 | DE10051321A1 New 2-(4-amino-piperidin-1-yl)-2-aryl-N-(phenylalkyl)-acetamides, are potent neurokinin antagonists, useful e.g. for treating allergic, inflammatory or central nervous system diseases |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | CA2426337A1 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 04/25/2002 | CA2425911A1 Methods for the preparation of biphenyl isoxazole sulfonamides |
| 04/25/2002 | CA2423792A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 04/25/2002 | CA2423599A1 Methods of producing oxazolidinone compounds |
| 04/24/2002 | EP0714299B1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 04/24/2002 | CN1346354A Substituted benzoylpyrazoles as herbicides |
| 04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
| 04/24/2002 | CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia |
| 04/24/2002 | CN1346271A Quinazoline derivatives as angiogenesis inhibitors |
| 04/24/2002 | CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 04/24/2002 | CN1083445C Thiodepsipeptides for combating endoparasites and a method for producing the same |
| 04/24/2002 | CN1083443C 吲哚衍生物 Indole derivatives |
| 04/24/2002 | CN1083439C 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators |
| 04/24/2002 | CN1083431C Novel heterocyclic compounds |
| 04/23/2002 | US6376548 Enhanced propertied pesticides |
| 04/23/2002 | US6376538 Antiinflammatory agents; autoimmune diseases |
| 04/23/2002 | US6376520 Pesticides |
| 04/23/2002 | US6376507 NK-1 receptor antagonists for the treatment of neuronal injury and stroke |
| 04/23/2002 | US6376503 Alpha 1a adrenergic receptor antagonists |
| 04/23/2002 | US6376499 Piperazine-amide compound with anticoagulant activity |
| 04/23/2002 | US6376491 Benzofuran derivatives for treatment or prevention of mycosis in mammals |
| 04/23/2002 | US6376490 Strong n-methyl-d-asparate receptor antagonists; useful in treating strokes, ischemia, and central nervous system injuries |
| 04/23/2002 | US6376487 Oxadiazine derivatives |
| 04/23/2002 | US6376485 Benzoxazoles with PDE-inhibiting activity |
| 04/23/2002 | US6376484 For prevention and/or treatment of various kinds of inflammatory disease |
| 04/23/2002 | US6376230 Stereoselective process for producing intermediates of cryptophycins |
| 04/18/2002 | WO2002030929A1 Novel pleuromutilin derivatives |
| 04/18/2002 | WO2002030927A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 04/18/2002 | WO2002030925A1 Benzopyranyl heterocycle derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 04/18/2002 | WO2002030923A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 04/18/2002 | WO2002030907A1 Pyrazole derivatives for the treatment of viral diseases |
| 04/18/2002 | WO2002030895A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS |
| 04/18/2002 | WO2002030890A1 Nitrogenous five-membered ring compounds |
| 04/18/2002 | WO2002008177A8 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 04/18/2002 | WO2001087830A3 Substituted thioacetamides |
| 04/18/2002 | WO2001026656A3 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/18/2002 | WO2000066106A9 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 04/18/2002 | US20020045771 Reacting 7-OH-protected baccatin III with 3-tert-butyl-2,2-dimethyl4-phenyloxazolidine-5-carboxylic acid |
| 04/18/2002 | US20020045654 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 04/18/2002 | US20020045652 Prophylactic or therapeutic drug for renal diseases |
| 04/18/2002 | US20020045642 Antiinflammatory, -arthritic and -emetic agents; central nervous system disorders; Parkinson's disease; antidepressants; psychological disorders; anxiolytic agents; antagonists of substance P receptors |
| 04/18/2002 | US20020045641 Multiple heteroatom containing heterocyclic ring compounds substituted with carboxylic acids and isosteres thereof |
| 04/18/2002 | US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/18/2002 | US20020045625 Oxazolidinone chemotherapeutic agents |
| 04/18/2002 | US20020045620 Readily metabolized by the metabolic drug detoxification systems; metabolized by serum or intracellular hydrolases and esterases; shorthalf-life; noninsulin-dependent diabetes mellitus (NIDDM) (Type II); side effect reduction |
| 04/18/2002 | US20020045619 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 04/18/2002 | US20020045616 Lactam inhibitors of FXa and method |
| 04/18/2002 | US20020044899 Controlled, super-fine grinding so particles react completely during leaching; extraction of copper from copper sulfide ores and concentrates |
| 04/18/2002 | CA2427499A1 Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-.gamma. binding agents |
| 04/18/2002 | CA2425416A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 04/18/2002 | CA2424802A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 04/18/2002 | CA2423515A1 Pyrazole derivatives for the treatment of viral diseases |
| 04/17/2002 | EP1197493A1 Benzimidazole compounds |
| 04/17/2002 | EP1197226A1 Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof |